查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
歐洲類器官市場預測至 2030 年 - 區域分析 - 按器官類型、應用、來源和類型
市場調查報告書
商品編碼
1402761

歐洲類器官市場預測至 2030 年 - 區域分析 - 按器官類型、應用、來源和類型

Europe Organoids Market Forecast to 2030 - Regional Analysis - by Organ Type, Application, Source, and Type
出版日期: | 出版商: The Insight Partners | 英文 99 Pages | 訂單完成後即時交付

價格

歐洲類器官市場預計將從2022年的8.4219億美元成長到2030年的40.8052億美元。預計2022年至2030年CAGR為21.8%。

歐洲類器官市場擴大採用個人化藥物

個人化醫療，也稱為精準醫療，是一種根據預期的反應或疾病風險為個別患者量身定製程序或藥物的醫療模式。根據個人化醫療聯盟(PMC) 發表的一項研究，2005 年個人化藥物僅佔FDA 批准的新分子實體的5%，而2016 年則佔了25% 以上。此外，佔所有化合物和藥物的42 % 73% 的研發中腫瘤化合物有潛力成為個人化藥物。此外，生物製藥公司在過去五年中對個人化藥物的研發投入幾乎加倍，未來五年可能會增加33%。生物製藥研究人員也預測，未來五年個人化藥物的開發將成長 69%。

使用類器官來創建個人化藥物療法為改善患者護理提供了令人興奮的機會。此外，藥劑師在增加個人化藥物需求方面發揮著重要作用，因為他們積極宣傳精準醫療並提高人們的意識。最近的研究表明，超過 50% 的消費者有興趣購買客製化產品或服務。這種需求促使藥物研究發展出更有針對性的治療方法，使藥物更安全、更有效。

個人化癌症醫學是一種根據腫瘤基因組特徵為每位患者制定有效治療策略的方法。對個人化腫瘤模型研究的需求不斷增加，以確認臨床前環境中基因組藥物反應預測的功能。許多研究強調了腫瘤類器官在個人化癌症醫學中在基因藥物關聯治療、新療法鑑定和患者預後預測方面的應用。

個人化癌症治療對每位患者進行特定的治療。使用與原始腫瘤具有相似特徵的個人化腫瘤模型可能會準確預測患者的藥物反應。腫瘤類器官模型有幾個優點，例如與預先存在的模型相比，保留了原始腫瘤的分子和細胞組成。這些優點凸顯了腫瘤類器官在個人化癌症治療中的巨大潛力，特別是在臨床前藥物篩選和預測患者對選定治療方案的反應。

歐洲類器官市場概況

歐洲類器官市場細分為德國、法國、義大利、英國、西班牙和歐洲其他地區。區域市場的成長與組織工程和器官移植的需求不斷成長有關；擴大採用類器官進行疾病建模、基因突變和腫瘤建模；以及不斷成長的類器官研究活動。此外，資金增加和公私投資等因素可能會在未來幾年為該地區帶來更多機會。

歐洲類器官市場收入及 2030 年預測（百萬美元）

歐洲類器官市場細分

歐洲類器官市場分為器官類型、類型、應用、來源和國家。

依器官類型，歐洲類器官市場分為腸、肝、胃、胰臟、肺、腦、腎等。 2022 年，腸道領域在歐洲類器官市場中佔最大佔有率。

根據類型，歐洲類器官市場分為儀器、消耗品和服務。 2022 年，消耗品領域在歐洲類器官市場中佔最大佔有率。

根據應用，歐洲類器官市場分為發育生物學疾病、傳染病病理學、再生醫學、藥物毒性和功效測試、藥物發現和個人化醫療等。到 2022 年，發育生物學疾病領域將佔據歐洲類器官市場的最大佔有率。

根據來源，歐洲類器官市場分為多能幹細胞和器官特異性成體幹細胞。到 2022 年，多能幹細胞細分市場將在歐洲類器官市場中佔據更大佔有率。

根據國家/地區，歐洲類器官市場分為德國、法國、英國、義大利、西班牙和歐洲其他地區。 2022 年，德國在歐洲類器官市場佔據主導地位。

Cellesce、Definigen、Hubrecht Organoid Technology、InSphero、Merck KGaA、STEMCELL Technologies Inc 和 Thermo Fisher Scientific Inc 是歐洲類器官市場上的一些領先公司。

目錄

第 1 章：簡介

  • Insight Partners 研究報告指南
  • 市場區隔

第 2 章：執行摘要

  • 歐洲關鍵見解
  • 歐洲市場吸引力

第 3 章：研究方法

  • 覆蓋範圍
  • 二次研究
  • 初步研究

第 4 章：歐洲類器官市場格局

  • 概述
  • 歐洲PEST分析

第 5 章：歐洲類器官市場 - 主要產業動態

  • 主要市場促進因素：
    • 對腫瘤建模和生物樣本庫的需求不斷增加
    • 擴大採用個人化藥物
    • 人們日益關注開發動物測試模型的替代方案
  • 主要市場限制：
    • 與將類器官涵蓋現有工作流程相關的問題
    • 缺乏熟練的專業人員
  • 主要市場機會：
    • 專注於藥物發現活動
  • 未來的趨勢：
    • 將類器官與器官晶片結合
  • 影響分析：

第 6 章：類器官市場 - 歐洲市場分析

  • 歐洲類器官市場收入，2022 - 2030

第 7 章：歐洲類器官市場 - 2030 年收入與預測 - 按器官類型

  • 概述
  • 2022 年及 2030 年歐洲類器官市場收入佔有率，依器官類型分類 (%)
  • 胃
  • 腸
  • 肝
  • 胰臟
  • 肺
  • 腦
  • 腎
  • 其他

第 8 章：歐洲類器官市場 - 收入和 2030 年預測 -按應用

  • 概述
  • 2022 年及 2030 年歐洲類器官市場收入佔有率，依應用分類 (%)
  • 發育生物學
  • 傳染病的疾病病理學
  • 再生醫學
  • 藥物毒性和藥效測試
  • 藥物發現與個人化醫療
  • 其他

第 9 章：歐洲類器官市場 - 收入和 2030 年預測 - 按來源

  • 概述
  • 2022 年及 2030 年歐洲類器官市場收入佔有率（按來源分類）（%）
  • 多能幹細胞
  • 器官特異性成體幹細胞

第 10 章：歐洲類器官市場 - 收入和 2030 年預測 - 按類型

  • 概述
  • 歐洲類器官市場收入佔有率，按類型 2022 年和 2030 年 (%)
  • 儀器
  • 耗材
  • 服務

第 11 章：歐洲類器官市場 - 國家分析

    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 歐洲其他地區

第 12 章：COVID-19 前後的影響

  • COVID-19 前後的影響

第 13 章：歐洲類器官市場產業格局

  • 概述
  • 市場上公司採取的成長策略，(%)
  • 有機發展
    • 概述
  • 無機發展
    • 概述

第 14 章：歐洲類器官市場，主要公司概況

  • STEMCELL Technologies Inc.
  • Cellesce Ltd
  • Hubrecht Organoid Technology
  • Definigen
  • Thermo Fisher Scientific Inc
  • Merck KGaA
  • InSphero

第 15 章：附錄

  • 關於我們
  • 專業術語
Product Code: TIPRE00018856

The Europe organoids market is expected to grow from US$ 842.19 million in 2022 to US$ 4,080.52 million by 2030. It is estimated to grow at a CAGR of 21.8% from 2022 to 2030.

Growing Adoption of Personalized Drugs in Europe Organoids Market

Personalized medicine, also known as precision medicine, is a medical model that practices procedures or drugs tailored to the individual patient based on the projected response or risk of disease. According to a study published by Personalized Medicine Coalition (PMC), personalized medicines accounted for only 5% of the new FDA-approved molecular entities in 2005, whereas they accounted for more than 25% in 2016. Additionally, 42% of all compounds and 73% of oncology compounds in the pipeline have the potential to be personalized medicines. Moreover, biopharmaceutical companies nearly doubled their R&D investment in personalized drugs over the past five years, which is likely to increase by 33% in the next five years. Biopharmaceutical researchers also predict a 69% increase in the development of personalized medicines over the coming five years.

The implementation of organoids to create personalized drug therapies provides exciting opportunities for improving patient care. In addition, pharmacists play an essential role in increasing the demand for personalized medicines as they proactively educate and create awareness about precision medicine. Recent research has highlighted that more than 50% of consumers are interested in purchasing customized products or services. This demand has persuaded pharmaceutical research to develop more tailored treatments to make medicines safer and more effective.

Personalized cancer medicine is an approach to tailoring effective therapeutic strategies for each patient according to a tumor's genomic characterization. There is an increasing demand for research in personalized tumor modeling to confirm the functional aspects of genomic drug response predictions in the preclinical setting. Numerous studies have highlighted the application of tumor organoids in personalized cancer medicine in terms of gene-drug association treatment, identification of new therapies, and prediction of patient outcomes.

Personalized cancer therapy applies specific treatments to each patient. Using personalized tumor models with similar characteristics to the original tumors may result in accurate predictions of drug responses in patients. Tumor organoid models have several advantages, such as conserving the molecular and cellular composition of the original tumor over pre-existing models. These advantages highlight the tremendous potential of tumor organoids in personalized cancer therapy, particularly in preclinical drug screening and predicting patient responses to selected treatment regimens.

Europe Organoids Market Overview

The Europe organoids market is sub-segmented into Germany, France, Italy, the UK, Spain, and the Rest of Europe. The regional market growth is associated with the rising demand for tissue engineering and organ transplantation; increasing adoption of organoids for disease modeling, gene mutation, and tumor modeling; and growing research activities on organoids. In addition, factors such as increased funding and public-private investments will likely add more opportunities in the coming years in the region.

Europe Organoids Market Revenue and Forecast to 2030 (US$ Million)

Europe Organoids Market Segmentation

The Europe organoids market is segmented into organ type, type, application, source, and country.

Based on organ type, the Europe organoids market is segmented into intestine, liver, stomach, pancreas, lung, brain, kidney, and others. The intestine segment held the largest share of the Europe organoids market in 2022.

Based on type, the Europe organoids market is segmented into instruments, consumables, and services. The consumables segment held the largest share of the Europe organoids market in 2022.

Based on application, the Europe organoids market is segmented into developmental biology disease, pathology of infectious disease, regenerative medicine, drug toxicity and efficacy testing, drug discovery and personalized medicine, and others. The developmental biology disease segment held largest share of the Europe organoids market in 2022.

Based on source, the Europe organoids market is bifurcated into pluripotent stem cells and organ-specific adult stem cell. The pluripotent stem cells segment held a larger share of the Europe organoids market in 2022.

Based on country, the Europe organoids market is segmented into the Germany, France, the United Kingdom, Italy, Spain, and the Rest of Europe. Germany dominated the Europe organoids market in 2022.

Cellesce, Definigen, Hubrecht Organoid Technology, InSphero, Merck KGaA, STEMCELL Technologies Inc, and Thermo Fisher Scientific Inc are some of the leading companies operating in the Europe organoids market.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe organoids market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in Europe organoids market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Europe Key Insights
  • 2.2 Europe Market Attractiveness

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Europe Organoids Market Landscape

  • 4.1 Overview
  • 4.2 Europe PEST Analysis

5. Europe Organoids Market - Key Industry Dynamics

  • 5.1 Key Market Drivers:
    • 5.1.1 Increasing Demand for Tumor Modeling and Biobanking
    • 5.1.2 Growing Adoption of Personalized Drugs
    • 5.1.3 Rising Focus on Developing Alternatives for Animal Testing Models
  • 5.2 Key Market Restraints:
    • 5.2.1 Issues Related to Incorporation of Organoids into Existing Workflows
    • 5.2.2 Dearth of Skilled Professionals
  • 5.3 Key Market Opportunities:
    • 5.3.1 Focus on Drug Discovery Activities
  • 5.4 Future Trends:
    • 5.4.1 Combining Organoid with Organ-On-A-Chip
  • 5.5 Impact Analysis:

6. Organoids Market - Europe Market Analysis

  • 6.1 Europe Organoids Market Revenue (US$ Mn), 2022 - 2030

7. Europe Organoids Market - Revenue and Forecast to 2030 - by Organ Type

  • 7.1 Overview
  • 7.2 Europe Organoids Market Revenue Share, by Organ Type 2022 & 2030 (%)
  • 7.3 Stomach
    • 7.3.1 Overview
    • 7.3.2 Stomach: Europe Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Intestine
    • 7.4.1 Overview
    • 7.4.2 Intestine: Europe Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Liver
    • 7.5.1 Overview
    • 7.5.2 Liver: Europe Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.6 Pancreas
    • 7.6.1 Overview
    • 7.6.2 Pancreas: Europe Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.7 Lung
    • 7.7.1 Overview
    • 7.7.2 Lung: Europe Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.8 Brain
    • 7.8.1 Overview
    • 7.8.2 Brain: Europe Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.9 Kidney
    • 7.9.1 Overview
    • 7.9.2 Kidney: Europe Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.10 Others
    • 7.10.1 Overview
    • 7.10.2 Others: Europe Organoids Market - Revenue and Forecast to 2030 (US$ Million)

8. Europe Organoids Market - Revenue and Forecast to 2030 - by Application

  • 8.1 Overview
  • 8.2 Europe Organoids Market Revenue Share, by Application 2022 & 2030 (%)
  • 8.3 Developmental Biology
    • 8.3.1 Overview
    • 8.3.2 Developmental Biology: Europe Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Disease Pathology of Infectious Disease
    • 8.4.1 Overview
    • 8.4.2 Disease Pathology of Infectious Disease: Europe Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Regenerative Medicine
    • 8.5.1 Overview
    • 8.5.2 Regenerative Medicine: Europe Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.6 Drug Toxicity and Efficacy Testing
    • 8.6.1 Overview
    • 8.6.2 Drug Toxicity and Efficacy Testing: Europe Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.7 Drug Discovery and Personalized Medicine
    • 8.7.1 Overview
    • 8.7.2 Drug Discovery and Personalized Medicine: Europe Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.8 Others
    • 8.8.1 Overview
    • 8.8.2 Others: Europe Organoids Market - Revenue and Forecast to 2030 (US$ Million)

9. Europe Organoids Market - Revenue and Forecast to 2030 - by Source

  • 9.1 Overview
  • 9.2 Europe Organoids Market Revenue Share, by Source 2022 & 2030 (%)
  • 9.3 Pluripotent Stem Cells
    • 9.3.1 Overview
    • 9.3.2 Pluripotent Stem Cells: Europe Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Organ-specific Adult Stem Cells
    • 9.4.1 Overview
    • 9.4.2 Organ-specific Adult Stem Cells: Europe Organoids Market - Revenue and Forecast to 2030 (US$ Million)

10. Europe Organoids Market - Revenue and Forecast to 2030 - by Type

  • 10.1 Overview
  • 10.2 Europe Organoids Market Revenue Share, by Type 2022 & 2030 (%)
  • 10.3 Instruments
    • 10.3.1 Overview
    • 10.3.2 Instruments: Europe Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.4 Consumables
    • 10.4.1 Overview
    • 10.4.2 Consumables: Europe Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.5 Services
    • 10.5.1 Overview
    • 10.5.2 Services: Europe Organoids Market - Revenue and Forecast to 2030 (US$ Million)

11. Europe Organoids Market - Country Analysis

  • 11.1 Europe Organoids Market: Overview
    • 11.1.1 Europe Organoids Market by Country
      • 11.1.1.1 Germany
        • 11.1.1.1.1 Overview
        • 11.1.1.1.2 Germany Organoids Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.1.1.1.3 Germany Organoids Market, by Organ Type
        • 11.1.1.1.4 Germany Organoids Market, by Application
        • 11.1.1.1.5 Germany Organoids Market, by Source
        • 11.1.1.1.6 Germany Organoids Market, by Type
      • 11.1.1.2 UK
        • 11.1.1.2.1 Overview
        • 11.1.1.2.2 UK Organoids Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.1.1.2.3 UK Organoids Market, by Organ Type
        • 11.1.1.2.4 UK Organoids Market, by Application
        • 11.1.1.2.5 UK Organoids Market, by Source
        • 11.1.1.2.6 UK Organoids Market, by Type
      • 11.1.1.3 France
        • 11.1.1.3.1 Overview
        • 11.1.1.3.2 France Organoids Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.1.1.3.3 France Organoids Market, by Organ Type
        • 11.1.1.3.4 France Organoids Market, by Application
        • 11.1.1.3.5 France Organoids Market, by Source
        • 11.1.1.3.6 UK Organoids Market, by Type
      • 11.1.1.4 Italy
        • 11.1.1.4.1 Overview
        • 11.1.1.4.2 Italy Organoids Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.1.1.4.3 Italy Organoids Market, by Organ Type
        • 11.1.1.4.4 Italy Organoids Market, by Application
        • 11.1.1.4.5 Italy Organoids Market, by Source
        • 11.1.1.4.6 Italy Organoids Market, by Type
      • 11.1.1.5 Spain
        • 11.1.1.5.1 Overview
        • 11.1.1.5.2 Spain Organoids Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.1.1.5.3 Spain Organoids Market, by Organ Type
        • 11.1.1.5.4 Spain Organoids Market, by Application
        • 11.1.1.5.5 Spain Organoids Market, by Source
        • 11.1.1.5.6 Spain Organoids Market, by Type
      • 11.1.1.6 Rest of Europe
        • 11.1.1.6.1 Overview
        • 11.1.1.6.2 Rest of Europe Organoids Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.1.1.6.3 Rest of Europe Organoids Market, by Organ Type
        • 11.1.1.6.4 Rest of Europe Organoids Market, by Application
        • 11.1.1.6.5 Rest of Europe Organoids Market, by Source
        • 11.1.1.6.6 Rest of Europe Organoids Market, by Type

12. Pre & Post COVID-19 Impact

  • 12.1 Pre & Post COVID-19 Impact

13. Europe Organoids Market Industry Landscape

  • 13.1 Overview
  • 13.2 Growth Strategies Done by the Companies in the Market, (%)
  • 13.3 Organic Developments
    • 13.3.1 Overview
  • 13.4 Inorganic Developments
    • 13.4.1 Overview

14. Europe Organoids Market, Key Company Profiles

  • 14.1 STEMCELL Technologies Inc.
    • 14.1.1 Key Facts
    • 14.1.2 Business Description
    • 14.1.3 Products and Services
    • 14.1.4 Financial Overview
    • 14.1.5 SWOT Analysis
    • 14.1.6 Key Developments
  • 14.2 Cellesce Ltd
    • 14.2.1 Key Facts
    • 14.2.2 Business Description
    • 14.2.3 Products and Services
    • 14.2.4 Financial Overview
    • 14.2.5 SWOT Analysis
    • 14.2.6 Key Developments
  • 14.3 Hubrecht Organoid Technology
    • 14.3.1 Key Facts
    • 14.3.2 Business Description
    • 14.3.3 Products and Services
    • 14.3.4 Financial Overview
    • 14.3.5 SWOT Analysis
    • 14.3.6 Key Developments
  • 14.4 Definigen
    • 14.4.1 Key Facts
    • 14.4.2 Business Description
    • 14.4.3 Products and Services
    • 14.4.4 Financial Overview
    • 14.4.5 SWOT Analysis
    • 14.4.6 Key Developments
  • 14.5 Thermo Fisher Scientific Inc
    • 14.5.1 Key Facts
    • 14.5.2 Business Description
    • 14.5.3 Products and Services
    • 14.5.4 Financial Overview
    • 14.5.5 SWOT Analysis
    • 14.5.6 Key Developments
  • 14.6 Merck KGaA
    • 14.7.1 Key Facts
    • 14.7.2 Business Description
    • 14.7.3 Products and Services
    • 14.7.4 Financial Overview
    • 14.7.5 SWOT Analysis
    • 14.7.6 Key Developments
  • 14.7 InSphero
    • 14.8.1 Key Facts
    • 14.8.2 Business Description
    • 14.8.3 Products and Services
    • 14.8.4 Financial Overview
    • 14.8.5 SWOT Analysis
    • 14.8.6 Key Developments

15. Appendix

  • 15.1 About Us
  • 15.2 Glossary of Terms

List Of Tables

  • Table 1. Europe Organoids Market Segmentation
  • Table 2. Germany Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Organ Type
  • Table 3. Germany Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Application
  • Table 4. Germany Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Source
  • Table 5. Germany Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Type
  • Table 6. UK Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Organ Type
  • Table 7. UK Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Application
  • Table 8. UK Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Source
  • Table 9. UK Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Type
  • Table 10. France Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Organ Type
  • Table 11. France Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Application
  • Table 12. France Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Source
  • Table 13. UK Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Type
  • Table 14. Italy Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Organ Type
  • Table 15. Italy Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Application
  • Table 16. Italy Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Source
  • Table 17. Italy Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Type
  • Table 18. Spain Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Organ Type
  • Table 19. Spain Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Application
  • Table 20. Spain Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Source
  • Table 21. Spain Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Type
  • Table 22. Rest of Europe Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Organ Type
  • Table 23. Rest of Europe Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Application
  • Table 24. Rest of Europe Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Source
  • Table 25. Rest of Europe Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Type
  • Table 26. Organic Developments Done by Companies
  • Table 27. Inorganic Developments Done by Companies
  • Table 28. Glossary of Terms, Europe Organoids Market

List Of Figures

  • Figure 1. Europe Organoids Market Segmentation, By Country
  • Figure 2. Europe - PEST Analysis
  • Figure 3. Europe Organoids Market - Key Industry Dynamics
  • Figure 4. Impact Analysis of Drivers and Restraints
  • Figure 5. Europe Organoids Market Revenue (US$ Mn), 2022 - 2030
  • Figure 6. Europe Organoids Market Revenue Share, by Organ Type 2022 & 2030 (%)
  • Figure 7. Stomach: Europe Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Intestine: Europe Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Liver: Europe Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. Pancreas: Europe Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Lung: Europe Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Brain: Europe Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Kidney: Europe Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Others: Europe Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Europe Organoids Market Revenue Share, by Application 2022 & 2030 (%)
  • Figure 16. Developmental Biology: Europe Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Disease Pathology of Infectious Disease: Europe Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Regenerative Medicine: Europe Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Drug Toxicity and Efficacy Testing: Europe Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. Drug Discovery and Personalized Medicine: Europe Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. Others: Europe Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. Europe Organoids Market Revenue Share, by Source 2022 & 2030 (%)
  • Figure 23. Pluripotent Stem Cells: Europe Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 24. Organ-specific Adult Stem Cells: Europe Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 25. Europe Organoids Market Revenue Share, by Type 2022 & 2030 (%)
  • Figure 26. Instruments: Europe Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 27. Consumables: Europe Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 28. Services: Europe Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 29. Europe Organoids Market, By Country - Revenue (2022) ($Mn)
  • Figure 30. Europe Organoids Market, By Key Countries, 2022 And 2030 (%)
  • Figure 31. Germany Organoids Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 32. UK Organoids Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 33. France Organoids Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 34. Italy Organoids Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 35. Spain Organoids Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 36. Rest of Europe Organoids Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 37. Pre & Post COVID-19 Impact
  • Figure 38. Growth Strategies Done by the Companies in the Market, (%)